Vabysmo Archives -

Roche’s third-quarter results have revealed a clear sign that the bumper sales boosting companies that have provided products

Roche Q3 results show steep fall-off in COVID product sales

https://pharmaphorum.com/news/roche-q3-results-show-steep-fall-off-in-covid-product-sales/

A higher dose of Regeneron and Bayer’s Eylea given every three or four months has shown efficacy in

Eylea data gives Regeneron/Bayer a lift in ophthalmic diseases

https://pharmaphorum.com/news/eylea-data-gives-regeneron-bayer-a-lift-in-ophthalmic-diseases/

Roche has been trumpeting the rapid uptake of its new eye disease drug Vabysmo as it takes on

Roche’s fast-growing eye drug Vabysmo set for EU approval

https://pharmaphorum.com/news/roches-fast-growing-eye-drug-vabysmo-set-for-eu-approval/

The FDA has approved Roche’s much-anticipated faricimab for two major causes of blindness, setting up a market clash

Roche grabs FDA okay for would-be blockbuster eye drug faricimab

https://pharmaphorum.com/news/roche-grabs-fda-okay-for-would-be-blockbuster-eye-drug-faricimab/

Vabysmo